Piozena Tablet 30 mg contains Pioglitazone, an oral antihyperglycemic agent from the thiazolidinedione class, primarily used to manage type 2 diabetes mellitus. Pioglitazone works by enhancing the body’s sensitivity to insulin, allowing muscles, fat, and liver cells to use glucose more effectively. This reduces blood sugar levels, helps maintain long-term glycemic control, and targets a key underlying cause of type 2 diabetes: insulin resistance.
Piozena Tablet 30 mg is suitable for patients whose blood sugar is not adequately controlled by diet, exercise, or lower-dose antidiabetic medications. The higher 30 mg strength provides an option for patients requiring moderate dose escalation to achieve target glycemic levels while maintaining convenient once-daily oral administration.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Piozena Tablet 30 mg is indicated for:
Type 2 diabetes mellitus as monotherapy in patients intolerant to metformin
Combination therapy with other oral antidiabetic drugs such as metformin or sulfonylureas
Adjunct therapy with insulin when oral agents alone are insufficient
Improving insulin sensitivity in overweight patients with type 2 diabetes
It is important to combine Piozena therapy with dietary modifications, exercise, and lifestyle management to maximize effectiveness.
The usual starting dose for type 2 diabetes is 15–30 mg once daily, taken with or without food.
Dose adjustments may be made according to blood glucose response, up to a maximum of 45 mg daily.
Regular monitoring of fasting and postprandial blood sugar levels is recommended to evaluate treatment efficacy.
Liver function tests should be performed prior to starting therapy and periodically thereafter, as Pioglitazone is metabolized by the liver.
Administer the tablet at the same time each day to maintain steady blood levels.
Lowers blood sugar levels effectively by improving insulin sensitivity
Targets insulin resistance, a core mechanism of type 2 diabetes
Can be combined with other oral or injectable antidiabetic medications
Once-daily oral dosing enhances patient adherence and convenience
May improve lipid profile, including lowering triglycerides and increasing HDL cholesterol
Piozena Tablet 30 mg is generally well tolerated, but potential side effects include:
Weight gain due to fluid retention
Mild peripheral edema (swelling of the legs or ankles)
Headache or dizziness
Gastrointestinal disturbances, including nausea or diarrhea
Rare liver enzyme elevation or hepatotoxicity
Serious but less common side effects may include:
Exacerbation of heart failure in patients with pre-existing cardiac disease
Risk of bladder cancer with long-term use (requires monitoring and medical consultation)
Not suitable for type 1 diabetes or patients with diabetic ketoacidosis
Caution is advised in patients with heart failure or liver impairment
Inform the healthcare provider of all other medications, particularly insulin or other hypoglycemic agents, to prevent low blood sugar (hypoglycemia)
Use during pregnancy or breastfeeding only under medical supervision
Regular monitoring of blood sugar, liver function, and cardiovascular health is recommended during long-term therapy
Store below 30°C in a dry place, away from light and moisture. Keep out of reach of children. Do not use after the expiration date.
Piozena Tablet 30 mg offers an effective option for managing type 2 diabetes by improving insulin sensitivity and supporting long-term glycemic control, enhancing overall metabolic health when used under medical supervision.
Login Or Registerto submit your questions to seller
No none asked to seller yet